Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endothelin Receptor
    (6)
  • Apoptosis
    (3)
  • Estrogen Receptor/ERR
    (3)
  • PPAR
    (3)
  • Prostaglandin Receptor
    (3)
  • 5-HT Receptor
    (2)
  • PDE
    (2)
  • PDGFR
    (2)
  • TGF-beta/Smad
    (2)
  • Others
    (11)
Filter
Search Result
Results for "

arterial hypertension

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    54
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • Isotope Products
    6
    TargetMol | Isotope_Products
  • Disease Modeling
    1
    TargetMol | Disease_Modeling_Products
Traumatic Acid
Trans-2-Dodecenedioic Acid, Dodec-2-Enedioic Acid, 2E-Dodecenedioic Acid
T44546402-36-4
Traumatic Acid (Dodec-2-Enedioic Acid) is a product of the hydroperoxide lyase pathway in plants. Potential as a wound healing agent that stimulates cell division near a wound site to form a protective callus.
  • $34
In Stock
Size
QTY
Monocrotaline
Crotaline
T2803315-22-0
Monocrotaline is an 11-membered macrocyclic pyrrolizidine alkaloid extracted from the seeds of Crotalaria plants. It inhibits organic cation transporters OCT-1 and OCT-2, with IC50 values of 36.8 µM and 1.8 mM, respectively. Monocrotaline exhibits antitumor activity and shows certain cytotoxicity against liver cancer cells such as HepG2. It is also commonly used to induce pulmonary arterial hypertension models in rodents.
  • $41
In Stock
Size
QTY
MRE-269
MRE269, MRE 269, ACT-333679
T3S2007475085-57-5
MRE-269 (ACT-333679) is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269(ACT-333679) is used for the treatment of pulmonary arterial hypertension. MRE-269(ACT-333679) is an active metabolite of Selexipag (S253150).
  • $47
In Stock
Size
QTY